January 2021 - Pharmaceutical Market Europe

January 2021 - Pharmaceutical Market Europe
Published on 12 January 2021

Description:

How AstraZeneca is improving care for CKD, Gilead’s search for an effective COVID-19 treatment, the importance of pandemic preparedness

Preview:

28 articles from this collection:
PME COVER
PME COVER
3 - Comment
3 - Comment
4 - T40 2020 Edition
4 - T40 2020 Edition
5 - Contents
5 - Contents
6-7 - News
6-7 - News
8-9 - Coronavirus news
8-9 - Coronavirus news
10-11 - Coronavirus news
10-11 - Coronavirus news
12 - Darwin’s medicine
12 - Darwin’s medicine
13 - Rohit Khanna
13 - Rohit Khanna
14 - Mike Dixon
14 - Mike Dixon
15 - Stephanie Hall
15 - Stephanie Hall
16-17 AstraZeneca
16-17 AstraZeneca
18-19 - R&D Innovation
18-19 - R&D Innovation
20-21 ICON
20-21 ICON
22-23 - The search for effective drug treatments for COVID-19
22-23 - The search for effective drug treatments for COVID-19
24-25 - The pandemic preparedness paradox
24-25 - The pandemic preparedness paradox
26-27 - EU Emergency health fund
26-27 - EU Emergency health fund
28-30 - Transforming clinical trial data into a long-term asset
28-30 - Transforming clinical trial data into a long-term asset
32-34 - Mapping at launch
32-34 - Mapping at launch
35 - Communiqué Awards 2021
35 - Communiqué Awards 2021
36-37 - Think fast, be different
36-37 - Think fast, be different
38-39 - Achieving an agile supply chain
38-39 - Achieving an agile supply chain
40-41 - Medicinal data – what’s next for IDMP?
40-41 - Medicinal data – what’s next for IDMP?
42-44 - Appointments
42-44 - Appointments
45 - Healthcare Comms News
45 - Healthcare Comms News
46 - Q&A
46 - Q&A
47 - Recruitment
47 - Recruitment
48 - First in Human
48 - First in Human